Cargando…
Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs
The potent transcription inhibitor Actinomycin D is used with several cancers. Here, we report the discovery that this naturally occurring antibiotic inhibits two human neutral aminopeptidases, the cell-surface alanine aminopeptidase and intracellular methionine aminopeptidase type 2. These metallo-...
Autores principales: | Węglarz-Tomczak, Ewelina, Talma, Michał, Giurg, Mirosław, Westerhoff, Hans V., Janowski, Robert, Mucha, Artur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047675/ https://www.ncbi.nlm.nih.gov/pubmed/30034623 http://dx.doi.org/10.18632/oncotarget.25532 |
Ejemplares similares
-
MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state
por: Frottin, Frédéric, et al.
Publicado: (2016) -
N-Benzyl Residues as the P1′ Substituents in Phosphorus-Containing Extended Transition State Analog Inhibitors of Metalloaminopeptidases
por: Janiszewska, Kamila, et al.
Publicado: (2020) -
Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
por: Weglarz-Tomczak, Ewelina, et al.
Publicado: (2021) -
Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents
por: Han, Jing, et al.
Publicado: (2018) -
A MetAP2 inhibitor blocks adipogenesis, yet improves glucose uptake in cells
por: Siddik, Md Abu Bakkar, et al.
Publicado: (2019)